Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
3.870
+0.040 (1.04%)
Jul 9, 2026, 2:59 PM EDT - Market open
Adagene Market Cap
Adagene has a market cap or net worth of $255.7 million as of July 9, 2026. Its market cap has increased by 178.36% in one year.
Market Cap
255.70M
Enterprise Value
186.78M
1-Year Change
178.36%
Ranking
Category
Stock Price
$3.87
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $255.70M, a decrease of -68.21%. That is a compound annual growth rate of -19.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 255.70M | 187.05% |
| Dec 31, 2025 | 89.08M | 1.11% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Invivyd | 277.46M |
| Niagen Bioscience | 275.35M |
| Greenwich LifeSciences | 272.57M |
| Surrozen | 268.78M |
| Entrada Therapeutics | 266.83M |
| Coherus Oncology | 257.60M |
| Sol-Gel Technologies | 256.42M |
| Conexeu Sciences | 253.94M |